MichaelGuerreraMD
Pediatric Hematology & Oncology • Washington, DCAssociate Professor, Pediatrics, G Washington University School of Medicine & Hlth Sci
Dr. Guerrera is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 Michigan Ave Nw
Washington, DC 20010Phone+1 202-476-2800
Education & Training
Children's National Hospital/George Washington UniversityFellowship, Pediatric Hematology/Oncology, 1998 - 2001
University of ConnecticutResidency, Pediatrics, 1995 - 1998- Uconn School Of MedicineClass of 1995
Certifications & Licensure
DC State Medical License 1999 - 2027
MD State Medical License 2000 - 2026
VA State Medical License 2021 - 2026
American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Top Doctor Northern Virginia Magazine, 2020
- Top Doctor Washingtonian, 2015-2017, 2019
- Physician of the Year National Hemophilia Foundation, 2018
- Join now to see all
Clinical Trials
- A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD) Start of enrollment: 2017 Nov 06
Roles: Principal Investigator
Publications & Presentations
PubMed
- 2 citationsAdvance Care Planning for Children With Rare Diseases: A Pilot RCT.Maureen E Lyon, Jamie L Fraser, Jessica D Thompkins, Heidi Clark, Nicola Brodie
Pediatrics. 2024-06-01 - 3 citationsNeutralizing antidrug antibody to emicizumab in patients with severe hemophilia A: Case report of a first noninhibitor patient and review of the literature.Hande Kizilocak, Michael F Guerrera, Guy Young
Research and Practice in Thrombosis and Haemostasis. 2023-08-01 - 16 citationsReal-world cost estimates of initiating emicizumab in US patients with haemophilia A.Benjamin J. Samelson-Jones, Christine Guelcher, Jan G. Kuhn, Regina Butler, Gita Massey
Haemophilia. 2021-05-29
Abstracts/Posters
- Real-World Use of Emicizumab in Patients with Hemophilia with and without InhibitorsMichael F. Guerrera, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Peri-Procedural Management and Outcomes of Patients with Hemophilia on Emicizumab ProphylaxisMichael F. Guerrera, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
